Dudediligence.

Soligenix, Inc

SNGXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

21.6M

on 2026-06-30, from 658K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-16 reverse split; each bar's tip shows the count as filed.

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$6.4M

Agreement of 2026-01-23. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-07 is not read yet.

Cash

4 quarters

$9.8M on 2026-06-30 ÷ $2.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 25 of its filings are not read yet.

Also on file: a 1-for-2 reverse split, 2026-09-17 8-K ↗